Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
BEAM
Stock Latest News
Ratings
Beam Therapeutics: Compelling BEAM-302 Data and Manageable Safety Profile Underpin Buy Rating and Favorable Risk‑Reward
9d ago
BEAM
Premium
The Fly
Beam Therapeutics’ risto-cel shows efficacy in Sickle Cell Disease trial
17d ago
BEAM
Premium
The Fly
Beam Therapeutics price target raised to $68 from $64 at Citi
24d ago
BEAM
Premium
The Fly
Clear Street sees buying opportunity for Beam Therapeutics after study update
25d ago
BEAM
Premium
Ratings
Beam Therapeutics: BEAM-302’s Differentiated AATD Profile and Accelerated Path Support Buy Rating and $80 Target
25d ago
BEAM
Premium
The Fly
Beam Therapeutics announces safety, efficacy data from BEAM-302 trial
25d ago
BEAM
Premium
Company Announcements
Beam Therapeutics Restructures Base-Editing Licensing After Bio Palette Exit
1M ago
8K
BEAM
Premium
Company Announcements
Beam Therapeutics Earnings Call Highlights PKU Pivot
2M ago
BEAM
Premium
Ratings
Beam Therapeutics: Advancing Interventional Genetics With Strong Balance Sheet and Multiple Near-Term Catalysts Supporting Buy Rating
2M ago
BEAM
Premium
The Fly
Beam Therapeutics price target raised to $26 from $22 at RBC Capital
2M ago
BEAM
Premium
The Fly
Beam Therapeutics price target raised to $65 from $57 at Wedbush
2M ago
BEAM
Premium
The Fly
Beam Therapeutics price target raised to $75 from $74 at Canaccord
2M ago
BEAM
Premium
Ratings
Beam Therapeutics: Clinical Momentum, Platform Validation, and De‑Risked Financing Support Buy Rating and $47 Target
2M ago
BEAM
Premium
The Fly
Beam Therapeutics price target raised to $47 from $45 at BofA
2M ago
PFE
BEAM
Premium
The Fly
Kyverna Therapeutics appoints Sravan Emany, Andrew Miller to board
2M ago
BEAM
KYTX
Premium
The Fly
Beam Therapeutics announces $500M financing facility
2M ago
BEAM
Premium
Company Announcements
Beam Therapeutics Secures $500 Million Credit Facility
2M ago
8K
BEAM
Premium
The Fly
Beam Therapeutics reports Q4 EPS $2.33 vs ($1.09) last year
2M ago
BEAM
Premium
The Fly
Walmart downgraded, Etsy upgraded: Wall Street’s top analyst calls
2M ago
GE
RS
Premium
The Fly
Beam Therapeutics initiated with a Buy at Canaccord
2M ago
BEAM
Premium
The Fly
Beam Therapeutics initiated with a Buy at Canaccord
2M ago
BEAM
Premium
Market News
Cathie Wood Loads Up on Momentum Stocks after Earnings Rally. Should You Follow?
2M ago
PD
TER
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
